BiotechTube
Home/Pipeline/Cyto-MSC Diabetes Complications

Cyto-MSC Diabetes Complications

Diabetes-related Vascular Complications

Phase 2Active

Key Facts

Indication
Diabetes-related Vascular Complications
Phase
Phase 2
Status
Active
Company
Cytopeutics

About Cytopeutics

MSC‑based cell therapy platform with halal‑certified products for Asia‑Pacific clinical markets.

View full company profile

Therapeutic Areas

CardiovascularNeurologyMetabolicOphthalmologyOrthopedicsOncologyImmunology